Skip to main content
. Author manuscript; available in PMC: 2021 Mar 4.
Published in final edited form as: J Pharm Drug Deliv Res. 2021 Jan 11;10(1):196.

Figure 7:

Figure 7:

Comparison of the effects of all the treatment arms on SKBR3 and MCF7 cell lines after 48 hours of cell exposure to treatment (DLNP=Combination drug loaded nanoparticles, PTX=Paclitaxel solution, 17AAG=17AAG solution and PTX+17AAG=combination drug solution at half concentration of each drug).